TRON-Translationale Onkologie An Der Universitatsmedizin Der Johannes Gutenberg-Universitat Mainz Gemeinnutzige Gmbh

Patent Applications and Registrations

Patent applications and USPTO patent grants for TRON-Translationale Onkologie An Der Universitatsmedizin Der Johannes Gutenberg-Universitat Mainz Gemeinnutzige Gmbh.The latest application filed is for "claudin-6-specific immunoreceptors and t cell epitopes".

Company Profile

6.32.0

TRON-Translationale Onkologie An Der Universitatsmedizin Der Johannes Gutenberg-Universitat Mainz Gemeinnutzige Gmbh - Mainz N/A DE
TRON (Translationale Onkologie an der Universitatsmedizin der Johannes Gutenberg-Universitat Mainz Gemeinnutzige GmbH - Translationale Onkologie an der Universitatsmedi DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Claudin-6-specific immunoreceptors and t cell epitopes Grant 11,345,731 - Sahin , et al. May 31, 2	2022-05-31
Formulation for administration of RNA Grant 11,318,195 - Sahin , et al. May 3, 2	2022-05-03
Antibodies useful in cancer diagnosis Grant 11,279,757 - Mitnacht-Kraus , et al. March 22, 2	2022-03-22
Predicting immunogenicity of T cell epitopes Grant 11,222,711 - Sahin , et al. January 11, 2	2022-01-11
RNA replicon for versatile and efficient gene expression Grant 11,168,337 - Beissert , et al. November 9, 2	2021-11-09
Use of RNA for reprogramming somatic cells Grant 11,008,550 - Sahin , et al. May 18, 2	2021-05-18
Combination therapy involving antibodies against claudin 18.2 for treatment of pancreatic cancer Grant 10,946,069 - Sahin , et al. March 16, 2	2021-03-16
Peptide mimotopes of claudin 18.2 and uses thereof Grant 10,858,415 - Sahin , et al. December 8, 2	2020-12-08
Combination therapy involving antibodies against Claudin 18.2 for treatment of cancer Grant 10,813,996 - Sahin , et al. October 27, 2	2020-10-27
Monoclonal antibodies against claudin-18 for treatment of cancer Grant 10,738,108 - Sahin , et al. A	2020-08-11
Agents for treatment of claudin expressing cancer diseases Grant 10,717,780 - Sahin , et al.	2020-07-21
Methods and kits for the diagnosis of cancer Grant 10,705,089 - Hipfel , et al.	2020-07-07
Diagnosis and therapy of cancer involving cancer stem cells Grant 10,604,568 - Sahin , et al.	2020-03-31
Monoclonal anti-GT 468 antibodies for treatment of cancer Grant 10,596,256 - Sahin , et al.	2020-03-24
Method and kit for determining whether a subject shows an immune response Grant 10,550,430 - Sahin , et al. Fe	2020-02-04
RNA formulation for immunotherapy Grant 10,485,884 - Sahin , et al. Nov	2019-11-26
Methods and compositions for diagnosis and treatment of cancer Grant 10,429,392 - Sahin , et al. October 1, 2	2019-10-01
Claudin-6-specific immunoreceptors and T cell epitopes Grant 10,370,423 - Sahin , et al. August 6, 2	2019-08-06
Combination therapy involving antibodies against claudin 18.2 for treatment of pancreatic cancer Grant 10,314,890 - Sahin , et al.	2019-06-11
Tumor antigens for determining cancer therapy Grant 10,188,712 - Sahin , et al. Ja	2019-01-29
Individualized vaccines for cancer Grant 10,155,031 - Sahin , et al. Dec	2018-12-18
Agents for treatment of claudin expressing cancer diseases Grant 10,093,736 - Sahin , et al. October 9, 2	2018-10-09
Antibodies against claudin 18.2 useful in cancer diagnosis Grant 10,053,512 - Sahin , et al. August 21, 2	2018-08-21
Combination therapy involving antibodies against Claudin 18.2 for treatment of cancer Grant 10,022,444 - Sahin , et al. July 17, 2	2018-07-17
Particles comprising a shell with RNA Grant 9,950,065 - Sahin , et al. April 24, 2	2018-04-24
Antibodies against Claudin 18.2 useful in cancer diagnosis Grant 9,512,232 - Sahin , et al. December 6, 2	2016-12-06
Use of FLT3 ligand for enhancing immune responses in RNA immunization Grant 9,486,519 - Sahin , et al. November 8, 2	2016-11-08
Combination therapy involving antibodies against claudin 18.2 for treatment of cancer Grant 9,433,675 - Sahin , et al. September 6, 2	2016-09-06
Vaccine composition comprising 5'-cap modified RNA Grant 9,295,717 - Sahin , et al. March 29, 2	2016-03-29

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.